Motif Neurotech is a pioneering Houston-based startup founded in 2022, dedicated to transforming mental health treatment through innovative technology. Unlike many brain-computer interface companies that focus on enabling communication for paralyzed individuals, Motif is at the forefront of addressing mental health disorders, particularly severe depression. Their groundbreaking device, a blueberry-sized brain implant, has recently received FDA approval for human trials. This implant is designed to deliver electrical stimulation to the skull, targeting the central executive network of the brain, which is often underactive in depression.

With the goal of restoring neuroplasticity, Motif’s device allows patients to receive therapeutic brain stimulation conveniently at home through a specially designed baseball cap. This cap controls the stimulation dosage and is used in short sessions throughout the day. The upcoming study aims to confirm the safety of the implant while also evaluating improvements in patients’ wellbeing and cognitive functions. Motif Neurotech is poised to redefine mental health treatment with its personalized and non-invasive approach.